Ventilated | Unventilated | |
No of patients IgG antibodies to: | 11 | 34 |
n (%) | n (%) | |
cM1/M2 | 0 (0%) | 0 (0%) |
cM1/D1a | 1 (9%) | 8 (24%) |
cM1/D1b | 5 (45%) | 6 (17%) |
cM1/T1a | 3 (27%) | 17 (50%) |
cM1/T1b | 2 (18%) | 3 (9%) |
cM1/Q1b | 3 (27%) | 14 (41%) |
cM2/D1a | 0 (0%) | 1 (3%) |
cM2/D1b | 0 (0%) | 1 (3%) |
cM2/T1a | 2 (18%) | 7 (21%) |
cM2/T1b | 1 (9%) | 1 (3%) |
cM2/Q1b | 1 (9%) | 12 (35%) |
cD1a/D1b | 3 (27%) | 3 (9%) |
cD1a/T1a | 4 (36%) | 12 (35%) |
cD1a/T1b | 2 (18%) | 1 (3%) |
cD1a/Q1b | 3 (27%) | 12 (35%) |
cD1b/T1a | 3 (27%) | 15 (44%) |
cD1b/T1b | 1 (9%) | 4 (12%) |
cD1b/Q1b | 2 (18%) | 12 (35%) |
cT1a/T1b | 3 (27%) | 15 (44%) |
cT1a/Q1b | 1 (9%) | 4 (12%) |
cT1b/Q1b | 3 (27%) | 10 (29%) |
Any of the above complexes | 9 (82%) | 29 (85%) |
cM1/D1a, designated complex of GM1 and GD1a; and similar in the following 20 antigens.